Clinical Trial Update: Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing efficacy and safety of lanthanum carbonate and sevelamer hydrochloride in patients on haemodialysis for end-stage renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• LANTHANUM CARBONATE (lanthanum carbonate)
• Sevelamer hydrochloride (sevelamer hydrochloride)

Snippet

Sponsor: Shire | Conditions: Kidney Failure, Chronic | Phase 3 | Status: COMPLETED